← All stocks

60 DEGREES PHARMACEUTICALS, INC.

SXTP Net buying
CIK 0001946563 #5496 in the set updated 19 Sep 2026
Bought (120 mo)
$255.27K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$255.27K
+$255.27K against sales at will

By person

8 insiders · 28 transactions
0.1×

Geoffrey Dow holds only 0.1 times base salary in stock. $33.26K of shares against $250.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Geoffrey Dow last reported holding, valued at $1.38, the price Common Stock was last bought or sold at on the open market here, on 12 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
DOW GEOFFREY S
President and CEO
$135.96K (11)
+$135.96K
24,131
$33.26K
XU CHERYL
Director
$119.31K (11)
+$119.31K
15,816
$21.80K
Knight Therapeutics Inc entity
Former 10% Owner
1,153,897
$1.59M
+3.9%
MILLER TYRONE
CFO
26,370
$36.35K
Allen Charles W
Director
14,000
$19.30K
+40.0%
TOOVEY STEPHEN
Director
14,000
$19.30K
+40.0%
FIELD PAUL
Director
14,000
$19.30K
+40.0%
Landon Kristen
Chief Operating Officer
4,540
$6.26K

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 1,472,891 to 4,230,448 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
DOW GEOFFREY S
12 Jun 2026
President and CEO
Buy
7,350
$1.38
$10.13K
DOW GEOFFREY S
15 Dec 2025
President and CEO
Buy
9,670
$0.80
$7.76K
DOW GEOFFREY S
11 Dec 2025
President and CEO
Buy
3,613
$0.92
$3.32K
DOW GEOFFREY S
10 Dec 2025
President and CEO
Buy
9,350
$0.95
$8.89K
XU CHERYL
3 Jun 2025
Director
Buy
2,000
$2.90
$5.80K
XU CHERYL
3 Jun 2025
Director
Buy
3,000
$2.87
$8.61K
XU CHERYL
16 Dec 2024
Director
Buy
2,000
$1.45
$2.90K
XU CHERYL
13 Dec 2024
Director
Buy
1,500
$1.52
$2.28K
XU CHERYL
13 Dec 2024
Director
Buy
1,500
$1.55
$2.33K
XU CHERYL
13 Dec 2024
Director
Buy
1,500
$1.58
$2.37K
XU CHERYL
13 Dec 2024
Director
Buy
1,500
$1.60
$2.40K
XU CHERYL
12 Dec 2024
Director
Buy
2,500
$1.80
$4.50K
XU CHERYL
12 Dec 2024
Director
Buy
2,500
$1.85
$4.63K
DOW GEOFFREY S
9 Dec 2024
President and CEO
Buy
35,823
$1.27
$45.56K
DOW GEOFFREY S
6 Dec 2024
President and CEO
Buy
20,579
$1.20
$24.67K
DOW GEOFFREY S
5 Dec 2024
President and CEO
Buy
17,549
$1.11
$19.52K
DOW GEOFFREY S
21 Nov 2024
President and CEO
Buy
3,500
$0.91
$3.20K
DOW GEOFFREY S
20 Nov 2024
President and CEO
Buy
1,000
$0.92
$924.30
DOW GEOFFREY S
19 Nov 2024
President and CEO
Buy
2,500
$0.90
$2.25K
XU CHERYL
27 Aug 2024
Director
Buy
5,000
$1.70
$8.50K
Allen Charles W
16 May 2024
Director
Exercised, kept
4,000
$0.22
$892.00
DOW GEOFFREY S
16 May 2024
President and CEO
Exercised, kept
17,000
$0.22
$3.79K
FIELD PAUL
16 May 2024
Director
Exercised, kept
4,000
$0.22
$892.00
XU CHERYL
16 May 2024
Director
Exercised, kept
2,000
$0.22
$446.00
DOW GEOFFREY S
12 Apr 2024
President and CEO
Exercised, kept
68,000
$0.27
$18.14K
XU CHERYL
31 Jan 2024
Director
Buy
200,000
$0.38
$75.00K
DOW GEOFFREY S
31 Jan 2024
President and CEO
Buy
25,974
$0.38
$9.74K
Knight Therapeutics Inc
28 Jul 2023
Former 10% Owner
Exercised, kept indirect
45,560
$4.75
$216.18K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 265,859
History held since 12 Jul 2023